Mar. 8, 2006 — BioForce Nanosciences Inc. has become a publicly traded company following its recently announced acquisition by Silver River Ventures Inc., now known as BioForce Nanosciences Holdings Inc. (OTC.BB: BFNH). BioForce will operate as the wholly owned subsidiary of BFNH.

The agreement was contingent upon the receipt of $2.5 million in escrow funds prior to the finalization of the acquisition process. The company said that the possibility exists for additional private placement capital and a secondary offering is anticipated for late 2006.

BioForce’s cornerstone technology is known as the NanoArrayer System. It is a biomolecular printing tool intended to impact the arena of cell biology with applications in molecular and cellular detection in a variety of clinical and non-clinical installations. Other products include the ViriChip System, the company’s proprietary ultra-micro detection system for viruses, and consumable printing tools and print surfaces, including proprietary SPT Surface Patterning Tools and Sindex Chips.

“BioForce has followed the tried and true model of beginning with a vision, then working for funding through grants, seed capital and other sources to fund research on nascent technology,” said Eric Henderson, who founded the company and continues to work as chief executive officer and chief science officer. “After 11 years, we are now reaching our long-term goal of bringing the first wave of new and innovative products to market.”